
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
REVIEW: CUTANEOUS MUCORMYCOSIS
Mayur D. Dorle*, Ashwini Bhivasane and Dr. Gajanan S. Sanap
. Abstract Diabetes Mallitus, burn patients, iron overload, extra use of corticosteroids etc. The signs and symptoms vary widely, and it is important to make the diagnosis as early as possible in order to achieve a better outcome. early diagnosis and multidisciplinary treatment should be offered to increase Survival A significant percentage of patients are at risk for cutaneous mucormycosis due to serious burns. The treatment is the chronic fungal infection caused by order of mucorals called as mucomycets. Is also called as black fungas. Mucormycosis is classified into five Types, a) Rhinocerebral (sinus and brain) mucormycosis, b) Pulmonary (lung) mucormycosis c) Gastrointestinal Mucormycosis mucormycosis, d), e) Disseminated mucormycosis. Cutaneous mucormycosis is the third most common clinical type of mucormycosis. Cutaneous mucormycosis Spreading of infection to skin, and various part of the skin such as face, upper extremities, lower extremities etc. Risk factors for the development of mucormycosis include, of choice is amphotericin B, but new azoles, such as posaconazole and isavuconazole, must be considered. Keywords: Cutaneous Mucormycosis, Black Fungus, Amphotericin B, Diabetes Mallitus. [Full Text Article] [Download Certificate] |
